Revance Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – RVNC
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 03 2025
0mins
Source: Globenewswire
Class Action Notice: Shareholders of Revance Therapeutics, Inc. (NASDAQ: RVNC) who purchased shares between February 29, 2024, and December 6, 2024, are encouraged to register for a class action lawsuit due to allegations of misleading statements and breaches related to a Distribution Agreement with Teoxane.
Next Steps for Shareholders: The deadline to seek lead plaintiff status is March 4, 2025, and registered shareholders will receive updates on the case without any cost or obligation to participate.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
